6,405 Shares in Masimo Corporation (NASDAQ:MASI) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH has made a new investment of approximately $1.07 million in Masimo Corporation, acquiring 6,405 shares during the first quarter.
• Research analysts have mixed opinions on Masimo's stock, with ratings ranging from "buy" to "hold" and price targets generally reduced, reflecting concerns about the company's performance.
• Masimo's latest earnings report indicated an EPS of $1.36, exceeding expectations, but the company has seen a 24.5% decline in revenue year-over-year.

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,405 shares of the medical equipment provider's stock, valued at approximately $1,067,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Envestnet Asset Management Inc. lifted its position in shares of Masimo by 17.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 31,107 shares of the medical equipment provider's stock valued at $5,142,000 after acquiring an additional 4,579 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Masimo by 58.4% during the first quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider's stock worth $123,000 after purchasing an additional 272 shares during the last quarter. Commonwealth Equity Services LLC purchased a new stake in shares of Masimo in the fourth quarter valued at $354,000. NBC Securities Inc. purchased a new stake in shares of Masimo in the first quarter valued at $61,000. Finally, Norges Bank purchased a new position in Masimo during the fourth quarter worth about $5,520,000. Hedge funds and other institutional investors own 85.96% of the company's stock.

Insider Transactions at Masimo

In other news, COO Bilal Muhsin sold 10,000 shares of Masimo stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the sale, the chief operating officer owned 24,172 shares of the company's stock, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 16.90% of the stock is owned by corporate insiders.

Masimo Stock Up 4.8%

Shares of NASDAQ:MASI traded up $7.32 during midday trading on Monday, reaching $161.27. The company had a trading volume of 962,017 shares, compared to its average volume of 549,034. The stock has a market capitalization of $8.74 billion, a P/E ratio of 30.79 and a beta of 1.21. The stock's fifty day moving average price is $162.89 and its 200-day moving average price is $165.27. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.17 and a quick ratio of 1.62. Masimo Corporation has a one year low of $101.61 and a one year high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.12. The business had revenue of $372.00 million during the quarter, compared to the consensus estimate of $367.79 million. Masimo had a positive return on equity of 22.56% and a negative net margin of 25.06%. The company's revenue for the quarter was down 24.5% compared to the same quarter last year. During the same period last year, the firm earned $0.77 earnings per share. Equities research analysts expect that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MASI. Wells Fargo & Company dropped their price objective on Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a report on Wednesday, May 7th. Wall Street Zen cut Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. BTIG Research reissued a "buy" rating on shares of Masimo in a research note on Monday, July 14th. Finally, Piper Sandler reissued an "overweight" rating and issued a $200.00 price objective (down from $215.00) on shares of Masimo in a research report on Wednesday, May 7th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $191.60.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.